Page 246 - Read Online

Qu et al. Etiological prevention of liver cancer

Patient consent China. J Med Virol 2002;67:447-50.
Not applicable. 19. Liang X, Cui F, Hadler S, Wang X, Luo H, Chen Y, Kane M, Shapiro
C, Yang W, Wang Y. Origins, design and implementation of the
China GAVI project. Vaccine 2013;31 Suppl 9:J8-14.
Ethics approval 20. Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William
Not applicable. DC, Sadovsky R, Morrison JM, Kellner A. Hepatitis B vaccine:
demonstration of efficacy in a controlled clinical trial in a high-risk
REFERENCES population in the United States. N Engl J Med 1980;303:833-41.
21. Maupas P, Chiron JP, Barin F, Coursaget P, Goudeau A, Perrin J,
1 Zhang Y, Ren JS, Shi JF, Li N, Wang YT, Qu C, Zhang Y, Dai M. Denis F, Mar ID. Efficacy of hepatitis B vaccine in prevention of early
International trends in primary liver cancer incidence from 1973 to HBsAg carrier state in children. Controlled trial in an endemic area
2007. BMC Cancer 2015;15:94. (Senegal). Lancet 1981;1:289-92.
2. Poon D, Anderson BO, Chen LT, Tanaka K, Lau WY, Van Cutsem 22. Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A. A
controlled clinical trial of the efficacy of the hepatitis B vaccine
E, Singh H, Chow WC, Ooi LL, Chow P, Khin MW, Koo WH; Asian
(Heptavax B): a final report. Hepatology 1981;1:377-85.
Oncology Summit. Management of hepatocellular carcinoma in Asia: 23. Chen DS. Hepatitis B vaccination: the key towards elimination and
consensus statement from the Asian Oncology Summit 2009. Lancet eradication of hepatitis B. J Hepatol 2009;50:805-16.
Oncol 2009;10:1111-8. 24. W.H.O. Scientific Group. Prevention of primary liver cancer. Report
3. de Martel C, Maucort-Boulch D, Plummer M, Franceschi S. World- on a meeting of a W.H.O. Scientific Group. Lancet 1983;1:463-5.
wide relative contribution of hepatitis B and C viruses in hepatocellular 25. Zanetti AR, Van Damme P, Shouval D. The global impact of
carcinoma. Hepatology 2015;62:1190-200. vaccination against hepatitis B: a historical overview. Vaccine
4. Ralphs S, Khan SA. The role of the hepatitis viruses in 2008;26:6266-73.
cholangiocarcinoma. J Viral Hepat 2013;20:297-305. 26. Zhu X, Zhang XL, Wang L. National EPI vaccination and hepatitis
5. Makvandi M. Update on occult hepatitis B virus infection. World J B vaccine coverage rate and the related factors: results from the 1999
Gastroenterol 2016;22:8720-34. nationwide survey. Chin J Vac Immunization 2000;6:193-7. (in Chinese)
6. Raimondo G, Pollicino T, Romanò L, Zanetti AR. A 2010 update on 27. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong
occult hepatitis B infection. Pathol Biol (Paris) 2010;58:254-7. X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H,
7. Chen CH, Changchien CS, Lee CM, Tung WC, Hung CH, Hu TH, Luo H, Li L, Jin S, Hadler SC, Wang Y. Epidemiological serosurvey
Wang JH, Wang JC, Lu SN. A study on sequence variations in pre-S/ of hepatitis B in China--declining HBV prevalence due to hepatitis B
surface, X and enhancer II/core promoter/precore regions of occult vaccination. Vaccine 2009;27:6550-7.
hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in 28. Wang FZ, Zhang GM, Shen LP, Zheng H, Wang F, Miao N, Yuan
Taiwan. Int J Cancer 2009;125:621-9. QL, Sun XJ, Bi SL, Liang XF, Wang HQ. Comparative analyze on
8. Wang M, Wang Y, Feng X, Wang R, Wang Y, Zeng H, Qi J, Zhao H, hepatitis B seroepidemiological surveys among population aged
Li N, Cai J, Qu C. Contribution of hepatitis B, C virus to liver cancer 1-29 years in different epidemic regions of China in 1992 and 2014.
in China North areas: experience from Chinese National Cancer Zhonghua Yu Fang Yi Xue Za Zhi 2017;51:462-8. (in Chinese)
Center. Int J Infect Dis 2017;65:15-21. 29. Finelli L, Bell BP. Chapter 4: Hepatitis B. Avaliable from: https://
9. Yin J, Zhang H, He Y, Xie J, Liu S, Chang W, Tan X, Gu C, Lu W, www.cdc.gov/vaccines/pubs/surv-manual/chpt04-hepb.pdf. [Last
Wang H, Bi S, Cui F, Liang X, Schaefer S, Cao G. Distribution and accessed on 19 Oct 2017]
hepatocellular carcinoma-related viral properties of hepatitis B virus 30. Chang MH, Lee CY, Chen DS, Hsu HC, Lai MY. Fulminant hepatitis
genotypes in Mainland China: a community-based study. Cancer in children in Taiwan: the important role of hepatitis B virus. J Pediatr
Epidemiol Biomarkers Prev 2010;19:777-86. 1987;111:34-9.
10. Cui Y, Jia J. Update on epidemiology of hepatitis B and C in China. J 31. Huang LM, Chang MH, Hong JY, Lee CY, Chen DS. Changing
Gastroenterol Hepatol 2013;28 Suppl 1:7-10. aetiologic patterns of acute viral hepatitis in Taiwanese children. J
11. Beath SV, Boxall EH, Watson RM, Tarlow MJ, Kelly DA. Fulminant Gastroenterol Hepatol 1989;4:339-44.
hepatitis B in infants born to anti-HBe hepatitis B carrier mothers. 32. Chiang CJ, Yang YW, You SL, Lai MS, Chen CJ. Thirty-year
BMJ 1992;304:1169-70. outcomes of the national hepatitis B immunization program in
12. Chang MH. Hepatitis B virus infection. Semin Fetal Neonatal Med Taiwan. JAMA 2013;310:974-6.
2007;12:160-7. 33. Qu C, Chen T, Fan C, Zhan Q, Wang Y, Lu J, Lu LL, Ni Z, Huang
13. Edmunds WJ, Medley GF, Nokes DJ, Hall AJ, Whittle HC. The F, Yao H, Zhu J, Fan J, Zhu Y, Wu Z, Liu G, Gao W, Zang M,
influence of age on the development of the hepatitis B carrier state. Wang D, Dai M, Hsia CC, Zhang Y, Sun Z. Efficacy of neonatal
Proc Biol Sci 1993;253:197-201. HBV vaccination on liver cancer and other liver diseases over 30-
14. Hyams KC. Risks of chronicity following acute hepatitis B virus year follow-up of the Qidong hepatitis B intervention study: a cluster
infection: a review. Clin Infect Dis 1995;20:992-1000. randomized controlled trial. PLoS Med 2014;11:e1001774.
15. Xia GL, Liu CB, Cao HL, Bi SL, Zhan MY, Su CA, Nan JH, Qi 34. Chen HL, Chang CJ, Kong MS, Huang FC, Lee HC, Lin CC, Liu
XQ. Prevalence of hepatitis B and C virus infections in the general CC, Lee IH, Wu TC, Wu SF, Ni YH, Hsu HY, Chen DS, Chang MH.
Chinese population: results from a nationwide cross-sectional Pediatric fulminant hepatic failure in endemic areas of hepatitis B
seroepidemiologic study of hepatitis A, B,C, D and E virus infections infection: 15 years after universal hepatitis B vaccination. Hepatology
in China, 1992. Int Hepatol Commun 1996;5:12. 2004;39:58-63.
16. Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history 35. Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, Chu
of HCV infection. Nat Rev Gastroenterol Hepatol 2013;10:553-62. HC, Wu TC, Yang SS, Kuo HS, Chen DS; Taiwan Hepatoma
17. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma Study Group. Decreased incidence of hepatocellular carcinoma in
and hepatitis B virus. A prospective study of 22 707 men in Taiwan. hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst
Lancet 1981;2:1129-33. 2009;101:1348-55.
18. Sun Z, Ming L, Zhu X, Lu J. Prevention and control of hepatitis B in 36. McMahon BJ, Bulkow LR, Singleton RJ, Williams J, Snowball M,
238 Hepatoma Research ¦ Volume 3 ¦ October 25, 2017